B. Balsara

发表

Chromosomal imbalances in human lung cancer

J. Testa, B. Balsara, 2002, Oncogene.

Detection of chromosomal aberrations by comparative genomic hybridization during transformation of human breast epithelial cells in vitro.

J. Russo, G. Balogh, B. Balsara, 2006, International journal of oncology.

Chromosome 17p13.2 transfer reverts transformation phenotypes and fas‐mediated apoptosis in breast epithelial cells

J. Russo, J. Testa, G. Mor, 2004, Molecular carcinogenesis.

Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas.

S. Manoir, J. Siegfried, E. Gabrielson, 1997, Cancer research.

Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma.

S. Jhanwar, J. Testa, B. Balsara, 1996, Cancer research.

Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas

J. Jen, E. Gabrielson, J. Testa, 2001, Genes, chromosomes & cancer.

Immunological, mutagenic & genotoxic investigations in gas exposed population of Bhopal.

G. Maru, A. Bhisey, B. Balsara, 1987, The Indian journal of medical research.

Neurofibromatosis 2 and malignant mesothelioma.

L. Pitts, J. Testa, A. De Rienzo, 2002, Neurology.

PDCD2 functions in cancer cell proliferation and predicts relapsed leukemia

R. Steward, A. Rabson, S. Minakhina, 2013, Cancer biology & therapy.

Functional roles of chromosomes 11 and 17 in the transformation of human breast epithelial cells in vitro.

J. Russo, J. Barrett, I. Russo, 1999, International journal of oncology.

Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism.

J. Testa, T. Colby, E. Henske, 2003, American journal of respiratory and critical care medicine.

Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma

S. Jhanwar, J. Testa, A. Rienzo, 2001, Oncogene.

Nuclear Factor-κB Modulation in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia

L. Goodell, A. Rabson, R. Strair, 2008, Clinical Cancer Research.

Advances in Brief Loss of Heterozygosity Analysis Defines a Critical Region in Chromosome Ip 22 Commonly Deleted in Human Malignant Mesothelioma 1

S. Jhanwar, J. Testa, B. Balsara, 2006 .

Establishment and characterization of four new squamous cell carcinoma cell lines derived from oral tumors

A. Bhisey, B. Balsara, R. Damle, 2005, Journal of Cancer Research and Clinical Oncology.

Flow cytometric DNA analysis of squamous cell carcinomas of the oral cavity: correlation with clinical and histopathological features.

A. Borges, S. Pradhan, R. Rajpal, 1994, European journal of cancer. Part B, Oral oncology.

T‐lymphoid blast crisis in chronic myeloid leukemia

G. Nanjangud, H. Malhotra, B. Balsara, 1991, American journal of hematology.

Cytogenetic features of erythroleukemia (EL). A study of 11 cases.

A. Bhisey, B. Balsara, P. Kadam, 1990, Cancer genetics and cytogenetics.

Rhabdomyosarcoma. A cytogenetically interesting case report.

B. Balsara, P. Parikh, P. Kadam, 1993, Cancer genetics and cytogenetics.

Cytogenetic studies on patients of acute lymphoblastic leukemia Burkitt's type with (8;14) & (14;18) translocations.

S. Pai, B. Balsara, P. Parikh, 1994, The Indian journal of medical research.

Loss of Methylthioadenosine Phosphorylase and Elevated Ornithine Decarboxylase Is Common in Pancreatic Cancer

J. Testa, H. Cooper, N. Meropol, 2004, Clinical Cancer Research.

Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions.

J. Testa, Y. Mitsuuchi, B. Balsara, 2004, Carcinogenesis.

Advances in the analysis of chromosome alterations in human lung carcinomas.

D. Bell, J. Testa, T. Taguchi, 1997, Cancer genetics and cytogenetics.

Characterization of unconventional MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice.

N. Copeland, N. Jenkins, C. Morton, 1997, Human molecular genetics.

Cytogenetics of Malignant Mesothelioma

J. Testa, B. Balsara, S. Apostolou, 2005 .

Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma.

S. Jhanwar, S. Manoir, D. Bell, 1999, Cancer research.

Comparative Genomic Hybridization and Loss of Heterozygosity Analyses Identify a Common Region of Deletion at 15 q 11 . 1 – 15 in Human Malignant Mesothelioma 1

S. Jhanwar, S. Manoir, D. Bell, 1999 .

Comparative genomic hybridization analysis.

J. Testa, B. Balsara, J. Pei, 2002, Methods in molecular medicine.

Human hepatocellular carcinoma is characterized by a highly consistent pattern of genomic imbalances, including frequent loss of 16q23.1–24.1

K. Buetow, J. Testa, A. De Rienzo, 2001, Genes, chromosomes & cancer.

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations

Sung-Bae Kim, K. Harrington, M. Ahn, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Renal oncocytoma with loss of chromosomes Y and 1 evolving to papillary carcinoma in connection with gain of chromosome 7. Coincidence or progression?

J. Testa, Hong Wu, R. Greenberg, 2005, Cancer genetics and cytogenetics.

Cloning and chromosomal localization of a gene encoding a novel serine/threonine kinase belonging to the subfamily of testis-specific kinases.

J. Testa, G. Kopf, P. Visconti, 2001, Genomics.

Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor.

Roland L. Dunbrack, R L Dunbrack, A. Godwin, 2000, Genomics.

HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma

J. Hopkins, D. Hong, C. Pickering, 2023, JCO precision oncology.

Randomized, open‐label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma

M. Kudo, S. Thongprasert, Yoon-Koo Kang, 2016, Hepatology.

Cytogenetic studies on a patient with prepubertal breast cancer: A case report

A. Bhisey, B. Balsara, R. Rao, 2005, Breast Cancer Research and Treatment.

A pilot study of allogeneic cellular therapy for patients with advanced hematologic malignancies.

R. Strair, B. Balsara, M. Anand, 2008, Leukemia research.

Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites.

J. Russo, I. Russo, B. Balsara, 2005, International journal of oncology.

Translocation t(1;21)(q21;p11) with trisomies X and 1q in a diffuse large B-cell lymphoma.

B. Balsara, P. Parikh, P. Kadam, 1994, Cancer genetics and cytogenetics.

Novel human and mouse annexin A10 are linked to the genome duplications during early chordate evolution.

N. Copeland, D. Gilbert, N. Jenkins, 1999, Genomics.

Phase II study of front-line dovitinib (TKI258) versus sorafenib in patients (Pts) with advanced hepatocellular carcinoma (HCC).

M. Kudo, S. Thongprasert, Yoon-Koo Kang, 2015 .

Abstract PR08: Preliminary results from a phase 2 trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

Sung-Bae Kim, K. Harrington, M. Ahn, 2019, Clinical Trials.